Saltar al contenido
ASGRAMUR
Asociación de Asma Grave de la Región de Murcia
Alternar navegación
Contacto
Junta Directiva
Actual
Anterior
¿Que hacemos?
¿Que hacemos?
Investigación
2025
Real-life effectiveness of tezepelumab in severe asthma
2024
Disease Modification in Asthma
Real-life effectiveness of tezepelumab in severe asthma
Effectiveness of Mepolizumab in Patients with Severe Eosinophilic Asthma with/without Nasal Polyposis: A Real-Life Study.
2023
Early Effectiveness of Dupilumab in Patients With Type 2 Severe Asthma: A Prospective Real-Life Study.
Tezepelumab in Patients With Severe Asthma: Response at 3 Months
Effectiveness of Benralizumab in Severe Eosinophilic Asthma Under Conditions of Routine Clinical Practice.
2022
Analysis of response of severe eosinophilic asthmatic patients to benralizumab.
Otros
Reuniones anteriores
ASGRAMUR
ASGRAMANGA
Otras reuniones
30/05/2025 | 31/05/2025
Programa ASGRAMANGA 2025
Por
asgramur
30/05/2025 | 31/05/2025
Alojamiento e inscripción
Por
asgramur
30/05/2025 | 31/05/2025
Galeria 2024
Por
asgramur